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THE ASSOCIATION BETWEEN SPIRITUALITY AND DEPRESSION IN 
PARKINSON’S DISEASE. Kwabena L. Blankson and Benjamin R. Doolittle. 
Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT. 
Spirituality has been an important coping mechanism for individuals struggling with a 
chronic illness. The objective of this pilot study is to correlate spirituality and depression 
in patients with Parkinson’s disease (PD). Individuals with PD belonging to support 
groups were solicited via mail and asked to complete a questionnaire consisting of 3 
parts: 1) basic patient information, 2) the Zung depression scale, and 3) the SIBS 
(Spiritual Involvement and Beliefs Scale). Among our sample (n=20), most were married 
(90%) and considered themselves spiritual (80%). 65% were depressed based on Zung 
Self-Depression Scale scores. A model based on non-linear relationships (quadratic 
model) revealed a significant correlation (p<0.05) between SIBS and depression scores, 
with a parabolic distribution of data points: patients with lower and higher spirituality 
scores had lower depression scores. Mid-range spirituality scores were associated with 
higher depression. The Existential/Meditative domain of the SIBS was negatively 
correlated to Zung scores (rs =-0.4927, p<0.05). Using multivariate regression analysis, 
our model that included age, gender, marital status, income, severity of PD, years with 
PD, and SIBS scores accounted for 92% of the variance of depression (R:=0.92, p<0.05), 
with gender and years with PD as the only significant variables (p<0.05). We conclude 
that spirituality is associated with depression in PD in a very specific way, and that 
healthcare providers should address a patient’s spirituality as an adjunct to 
pharmacotherapy in the treatment of depression in PD. 
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INTRODUCTION 
Parkinson’s disease: Diagnosis and Clinical Features 
Parkinson’s disease (PD) is a neurodegenerative disease that affects 3% of 
people over the age of 65 [1]. It affects over 1 million people in North America. 
Commonly underdiagnosed and misdiagnosed, PD is projected to pass cancer 
as the second most common cause of death among the elderly by 2040 [2], 
Mortality among PD patients is 2 to 3 times that of age-matched controls, and 
dementia occurs 6.6 times more frequently in elderly persons with PD 
compared to elderly controls [3-5]. The gold standard for diagnosis is not 
clinical but neuropathophysiologic, though no specific pathophysiologic 
hallmark exists to consistently make the diagnosis. 
PD is characterized by loss of an assortment of neurons, particularly 
dopaminergic neurons in the pars compacta of the substantia nigra, small 
cortical neurons, catecholinergic and serotonergic brain stem nuclei, and 
hypothalamic neurons, to name a few. As dopamine is essential for the 
coordination of muscles and movement, there are many motor manifestations 
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of PD, including tremor, rigidity, bradykinesia and gait disturbance. Treatment 
with dopamine (specifically levadopa) ameliorates the majority of these motor 
symptoms [6, 7], The presence of cytoplasmic inclusion bodies known as Lewy 
bodies is another pathophysiologic feature of PD, although Lewy bodies are 
found in other neurodegenerative diseases. The mechanism of Lewy body 
formation, as well as its role in the pathogenesis of PD, is poorly understood. 
The clinical syndrome was first described by James Parkinson in 1871 [8]. 
At the time, Parkinson may not have been fully aware of the emotional and 
psychological aspects of the disease he described as “shaking palsy.” Even 
today, health professionals continue to struggle to understand these non¬ 
movement related aspects of PD which include depression, dementia, anxiety, 
weight loss, sleep disturbance, and sexual dysfunction. 
Depression in Parkinson’s Disease 
Studies have estimated the prevalence rate of depression of PD patients to 
range between 25-40% [9-12]. In fact, depression is more common in PD as 
compared to those with a comparable disability[13]. In one particular study, 
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Menza et al. showed that PD patients had higher depression and anxiety 
scores than those with equal amounts of disability [14]. The authors concluded 
that depression in PD must go beyond a reactive psychological response and 
that there must be something intrinsic to PD that leads to higher depression 
scores. In this same study, depression was significantly correlated with a 
variety of variables such as Sevadopa dose, length of illness, disability score, 
and the harm avoidance personality trait. The harm avoidance personality trait 
(and other personality traits affected in PD) is thought to be mediated by the 
serotonin, and its correlation with depression scores lead to the authors’ 
suggestion that depression in PD is mediated more by serotonin, given 
dopamine’s poor track record in improving depression in PD. 
Clearly, the cause of depression in PD is likely multifactorial, mediated by 
both neurologic and psychological factors. Causes include but are not limited 
to changes in brain function caused by loss of dopaminergic neurons, 
serotonin and the unique and potentially frustrating challenges of living with 
PD [15], Mood changes can be directly attributed to changes brought upon by 
medication, most specifically the motor “on-off’ phases associated with taking 
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dopamine. Depression is less during an “on” state, when a PD patient’s 
levadopa is working well and bradykinesia and rigidity are ameliorated as 
compared to an “off” state, when the beneficial effects of levadopa have worn 
off and depression is increased [16]. One recent study has showed that 
depression in PD is an important predictor of mortality [17]. Advancing 
disease state, recent disease deterioration, occurrence of falls, and patients’ 
perceptions of handicap have all been associated with depression in PD [18, 
19]. 
Traditionally, treatment of depression has centered primarily on 
pharmacotherapy and sometimes psychotherapy as adjuvant treatment. 
Amongst those with PD, one study estimated that only 26% of PD patients 
received pharmacotherapy for treatment of depression [20]. Selective 
serotonin uptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) were 
the most utilized drugs for treatment of depression in this study that surveyed 
49 neurologists who cared for over 20,000 PD patients. And while the use of 
antidepressants appear to be widespread in PD, there have been very few 
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randomized controlled trials of antidepressants specifically in PD, none with 
definitive conclusions [21-23]. Clinicians continue to treat PD patients with 
antidepressants likely due to perceived general effectiveness and lack of other 
proven therapies. The question remains: why are PD patients treated with 
antidepressants if no sufficient data exists in favor of the effectiveness or 
safety of these drugs in PD [24], even when potential risks include inducement 
of parkinsonian symptoms, orthostatic hypotension, and serotonin syndrome? 
And what other potential therapies exist for treatment of depression in PD? 
Spirituality and Depression in PD 
Several studies which correlate religious commitment and mental health 
show a positive association between the two [25]. Larson et al. conducted a 
review of 2 leading psychiatric journals, compiling all the studies on spirituality 
and mental health over an 11 year period [26], 84% of those studies showed a 
positive association between spirituality and mental health. Many populations, 
from burn victims to urban poor, have shown that increased religious 
commitment correlated with decreased depression [27-29]. Doolittle et al. 
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surveyed 122 adult patients in an urban primary care clinic and found that 
spirituality and depression scores were negatively correlated; high spirituality 
scores predicted lower depression scores [29]. Cooper et al. found that 
African-American patients rated spirituality as important to depression care 3 
times more than whites did. 
There have, however, been no studies correlating spirituality and mental 
health specifically in PD. This finding can be partly explained by the poor 
understanding of the cause of depression in PD. Schrag et al. used the WHO 
model of impairment, disability and handicap to assess the factors that might 
contribute to depression in PD [18]. Using various instruments (Beck 
Depression Inventory, Hoehn and Yahr Disease Severity Scale, Schwab and 
England Disability Scale, Unified Parkinson’s Disease Rating Scale, and the 
Mini-Mental State Examination), the authors ascertained that higher 
depression scores were associated with advancing disease severity, recent 
disease deterioration, and occurrence of falls. They also found that patients’ 
perception of physical handicap more strongly influenced depression than 
actual physical handicap. 
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Leentjens and Verhey articulate the conceptual challenge of depression 
and Parkinson’s disease, concluding that depression associated with PD 
should be considered intrinsic to the disease, not stemming solely from either 
neurobiological or psychological etiologies [30], One issue that seems to 
confound the diagnosis of depression in PD is the overlapping 
symptomatology and pathophysiology. Depressed individuals and PD patients 
may both exhibit decreased appetite, sleep disturbances, psychomotor 
retardation and mental slowing. Both groups also undergo changes in 
neurochemistry, specifically in the serotonergic system. One can foresee the 
diagnostic challenge this poses to healthcare professionals: Is the patient 
exhibiting parkinsonism or depression, or is the Parkinson’s disease itself 
causing the depression? Leentjens and Verhey suggest an interdisciplinary 
treatment team for depression in PD including neurologist, psychiatrist and 
psychologist. 
A thorough MEDLINE literature review yielded no studies of spirituality and 
depression in the context of Parkinson’s disease. As a population, PD patients 
warrant study as their prevalence of depression is higher than the general 
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population, and the cause of their depression is clearly not based solely upon 
neurochemical brain changes. Pharmacotherapy only addresses one of the 
many potential causes of depression in PD patients. What role might 
spirituality play in the treatment or experience of depression in Parkinson’s 
disease? 
HYPOTHESIS 
There are unique challenges to the question of how to address depression 
in PD, and the purpose of this study is to explore the relationship between 
spirituality and depression in PD. We hypothesize that there will be a negative 
correlation between Zung depression scores and spirituality scores as 
measured by the Spiritual Involvement and Beliefs Scale (SIBS): patients with 
greater spirituality will be less likely to be depressed. 
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METHODOLOGY 
Design 
The study consisted of administering a survey containing three parts: 1) 
basic patient information, 2) Zung depression scale [31] , and 3) the SIBS 
(Spiritual Involvement and Beliefs Scale) [32]. Parkinson’s patients from 
across New England were solicited via mail. 
Subjects were identified via internet search through Parkinson’s support 
groups in the New England area. Using the website www.parkinson.org, 
Parkinson’s Disease support groups within 200 miles of New Haven were 
solicited through e-mail, letter, or phone. The support group coordinators were 
then asked to identify the members in their groups interested in participating in 
the study. Once identified, these subjects received surveys directly from the 
group coordinators (who received the surveys from the research team via mail). 
Participation in the study was voluntary, anonymous, and confidential. The 
study was approved by the Yale University School of Medicine Human 
Investigations Committee in October 2004. 
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Survey Instruments 
The survey contained three parts: 1) basic demographic information (e.g. 
age, gender, marital status) and a few general questions about health, religion 
and spirituality (e.g. severity of Parkinson’s disease, religious affiliation, “do 
you consider yourself religious,” “do you consider yourself spiritual”) 2) the 
Zung depression scale and 3) the Spiritual Involvement and Beliefs Scale 
(SIBS) (See Appendix). 
The Zung depression scale is a validated 20 question self-administered 
survey that assesses depression symptoms such as insomnia, weight loss, 
anhedonia, and irritability [31]. Questions are positively or negatively phrased, 
e.g. “My mind is as clear as it used to be,” “I feel down-hearted and blue.” 
Answers are scored on a 4 point Likert scale, with 4 representing the least 
favorable response. The raw score (the summation of point totals from the 20 
questions) is converted to a ‘Self-rating Depression Scale (SDS) index’, a 
depression-judging variable which is then interpreted against established 
grouping parameters. An SDS index of less than 50 is considered normal, 50 
to 59 mild depression, 60 to 69 moderate depression, and greater than 70 
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severe depression. As a predictor of depression, the Zung scale is widely used 
and its validity is well-established in the literature [33, 34]. 
The Spiritual Involvement and Beliefs Scale was designed by Robert Hatch 
and collaborators in 1998 as an instrument to assess spiritual status [32], 
Unlike other instruments before it, the ability of the SIBS to cross religious 
traditions is one of its strengths. Perspectives from multiple religions were 
solicited and key cross-religion principles were identified and stated in neutral 
language, avoiding catch words or phrases from particular religious or spiritual 
groups. The SIBS focus on action and not just belief gives it the ability to be a 
broader measurement of a person’s spirituality, a feature that separates it from 
other available instruments. This validated scale is comprised of 26 items 
scored on a 5 point Likert scale. In addition to an overall score, the items can 
be clustered into 4 different domains/factors, each with particular content 
(Table 1). Factor 1, labeled External/Ritual, is comprised of items that pertain 
to spiritual beliefs or rituals that are consistent with belief in a higher power. 
Factor 2, labeled Internal/Fluid, contains items related to an evolving or 
growing internal belief system. Factor 3, labeled Existential/Meditative, 
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contains items dealing with existential and meditative issues. Lastly, Factor 4, 
labeled Humility/Personal Application, deals with the application of spiritual 
principles to daily life. 
Table 1. The Four SIRS Factors/Domains 
DOMAIN Sample Questions 
Factor 1 Extemal/Ritual “I believe in a higher power” 
Factor 2 Intemal/Fluid “I probably will not reevaluate my religious beliefs” 
Factor 3 Existential/ “I prayed/meditated/participated in spiritual activities 
Meditative with another person x times last week” 
Factor 4 Humility/Personal “When I wrong someone, I make an effort to 
Application apologize” 
Analyses 
Raw data from completed questionnaires was compiled into a Microsoft 
Excel Database, and statistical analyses were conducted with JMP4 Statistical 
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Software. Several statistical methods were utilized. The SDS indices (obtained 
from the Zung) and the SIBS scores were compared via the Spearman’s rank 
correlation coefficient. Additional comparisons via Spearman’s rank correlation 
coefficient included Zung SDS indices and SIBS domains (Factors 1-4). Paired 
t tests were performed to compare Zung SDS indices against individual SIBS 
items divided into “high” and “low” spirituality categories, “high spirituality” 
defined as answers of “agree” and “strongly agree” and “low spirituality” as 
answers of neutral or below. Additionally, specific demographic factors and 
variables such as years with PD and severity of PD were compared to Zung 
SDS indices and SIBS domains via paired t tests. 
Chi square tests between depression and demographic attributes were also 
conducted. Multivariate regression analysis was performed to assess the 
impact of demographic variables, self-assessment of religiosity and spirituality, 
socioeconomic status, severity of PD, and years with PD. 
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Results 
One hundred and twenty surveys were mailed to support groups across the 
New England area. To date, twenty completed surveys have been received 
and processed. Since surveys were distributed to support group leaders based 
on estimates of maximum support group attendance, the number of surveys 
actually distributed is unknown. 
Table 2 summarizes the demographic data. The average age of 
respondents was 68 years old. 75% were male. The majority was married 
(85%), and only a few (10%) lived alone. More than half of the respondents 
(60%) lived with someone who helped them with their activities of daily living, 
and 90% lived with someone who helped them cope with their disease. 
Average income ranged from $40,000 to $60,000. In terms of symptom 
severity, most felt their symptoms were moderate (with none, mild, and severe 
being the other choices). The average length of Parkinson’s diagnosis was 10 
years. 
Respondents came from variety of religious traditions including Roman 
Catholic, Judaism, and Protestant. 55% answered “yes” to the question “Do 
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you consider yourself a religious person?” while 80% answered “yes” to “Do 
you consider yourself a spiritual person?” When asked to rank how important 
spirituality was in coping with disease on a scale of 1-10, the mean response 
was 7. Ranking on this scale was positively correlated with the validated 
measure of spirituality, the SIBS, specifically in the external (Factor 1) and 
internal (Factor 2) domains (rs =+0.5584, p<0.05, (rs =+0.5934, p<0.05, 
respectively). The suggestion is that for those who use spirituality in coping 
with their PD, external rituals (like weekly prayer, participating in spiritual 
activities with other people) and an evolving belief system are the primary 
spiritual avenues of coping with PD. 
The average Zung SDS index was 55 (sd +/- 10), meaning that the average 
respondent was mildly depressed. The prevalence of depression (as 
measured by Zung SDS scores) among respondents was 65%, much higher 
than the national estimates of depression in the general population [35] (10%) 
and also higher than estimates of depression in the Parkinson’s population 
(25-40%) [5-8]. One unexpected finding was the negative correlation between 
depression scores and years with PD (rs =-0.5342, p<0.05), suggesting that 
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the individuals who had lived with PD for a longer period of time were less 
depressed. 
Table 2. Demographic Characteristics of 20 Survey Respondents 
with Parkinson's Disease 
Characteristic Value 
Age, mean +/- SD 67.6+/- 10 
Gender 
Male 75% 
Marital Status 
Married 90% 
Ethnicity/Race 
Caucasian 60% 
Hispanic 10% 
Other/No response 30% 
Annual Income 
<$20,000 5% 
$20-40,000 25% 
$40-60,000 35% 
$60-80,000 10% 
>$80,000 25% 
Years lived with PD 9.7 
Parkinson’s Severity 
Mild 40% 
Moderate/Severe 60% 
Answered ‘Yes’ to the question: 
Do you live with someone who helps you 
cope with disease? 
90% 
Answered ‘Yes’ to the question: 
Do you consider yourself a religious 
person? 
55% 
Do you consider yourself a spiritual person? 80% 
Average score in response to 
On a scale of 1-10, how important is your 
support group in coping with your illness? 
Average score in response to 
5.8 +/- 2.3 
On a scale of 1-10, how important is your 
spirituality in coping with your illness? 
6.6 +/- 3.0 
Religious Affiliation 
Roman Catholic 25% 
Protestant 30% 
Jewish 5% 
No response/other 40% 
Zung Self Depression Scale Categories 
Normal 35% 
Mild depression 25% 
Moderate depression 35% 
Severe depression 5% 
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In spite of specifically targeting support groups, we paradoxically recruited 
a small number of respondents (2) who did not participate in support groups. 
Of the vast majority who did, 83% felt that their support group helped them 
cope with their illness. Amongst support group attendees in this study, 61% 
qualified as depressed. Spearman’s rank correlation coefficient between Zung 
scores and responses to the question “On a scale of 1-10, how important is 
your support group in coping with your illness?” (rs =+0.4841, p<0.05) 
corroborate the above data’s suggestion that individuals who choose to attend 
PD support groups are depressed and may do so to help cope with their PD 
and depression (See Table 2 for correlation coefficients). Spearman’s rank 
correlation coefficient showed positive correlation between responses to the 
question “Does your support group help you cope with your illness?” and “On a 
scale of 1-10, how important is spirituality in coping with your illness?” (rs 
=+0.4965, p<0.05). This relationship reflects that respondents who reported 
that support groups helped them cope also reported received support from 
their spirituality. 

Spearman’s rank correlation coefficient comparing SIBS scores to 
depression scores (Zung SDS indices) was not significant (rs =-0.2914, 
p>0.05), suggesting little linear correlation between spirituality and depression 
amongst Parkinson’s patients. Examining the data points on a plot, we tested 
a model based on non-linear relationships (quadratic model) and discovered a 
significant correlation (R2 =0.41, p<0.05) (Figure 1).The implications of this 
parabolic model are that least depressed PD individuals lie at the extremes of 
the spirituality spectrum, being either highly spiritual or not spiritual at all. 
Figure 1. Bivariate fit of depression scores (SDS index) by SIBS score 
One interesting linear correlation was found when comparing Zung scores 
to specific spirituality domains (Factors 1-4). While Factors 1,2 and 4 were not 
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statistically significant, Factor 3 (Existential/Meditative) was negatively 
correlated to Zung scores (rs =-0.4927, p<0.05), suggesting that the less 
depressed a person was, the more he or she identified with existential and 
meditative methods of spirituality. Specific questions posed in this domain 
were, “I can find meaning in times of hardship,” “My life has a purpose,” 
“Prayers do not really change what happens,” and questions on the number of 
times a person prayed last week, meditated last week, or participated in 
spiritual activities with another person last month. 
Table 2. Nonparametric Spearman's Rank Correlation Coefficients between Variables 
Variable by Variable 
Spearman’s 
Rho Probability 
Zung score (SDS index) SIBS score (total) -0.3385 0.1694 
Zung score (SDS index) SIBS EXTERNAL domain -0.1962 0.4353 
Zung score (SDS index) SIBS INTERNAL domain -0.2912 0.2411 
Zung score (SDS index) SIBS EXISTENTIAL domain -0.4951 0.0367 
Zung score (SDS index) SIBS HUMILITY domain -0.3027 0.2221 
Zung score (SDS index) age -0.0431 0.8652 
Zung score (SDS index) severity of PD -0.197 0.4333 
Zung score (SDS index) number of years with PD -0.4834 0.0421 
Zung score (SDS index) patient’s rank of utility of spirituality in coping with illness 0.1336 0.5973 
Zung score (SDS index) patient's rank of utility of support group in coping with illness 0.5038 0.0466 
SIBS score (total) age -0.2077 0.3934 
SIBS score (total) severity of PD 0.1401 0.5673 
SIBS score (total) number of years with PD 0.2384 0.3256 
SIBS score (total) patient's rank of utility of spirituality in coping with illness 0.4597 0.0500 
SIBS score (total) patient's rank of utility of support group in coping with illness -0.3747 0.1528 
SIBS EXTERNAL 0.5934 0.0094 
domain 
SIBS INTERNAL domain 
patient's rank of utility of spirituality in coping with illness 
patient's rank of utility of spirituality in coping with illness 0.5584 0.016 
*Significant correlations indicated by gray shading. 
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Paired t tests comparing the depressed and non-depressed to specific 
responses on items of the SIBS revealed significant differences only in 
responses to questions 11,20, and 23. The questions were as follows: 
11. My spiritual beliefs continue to evolve. 
20. When I wrong someone, S make an effort to apologize. 
23. I examine my actions to see if they reflect my values. 
The trend of responses across the three questions was that respondents with 
high Zung scores answered these questions on the lower end of the scale 
(“neutral”, “disagree”, “strongly disagree”) as compared to respondents with 
low Zung scores. 
Chi square analysis showed no significant difference between depression 
and any of the demographic factors (i.e.. age, gender, income, etc.). While 
other studies have suggested severity of illness is associated with worsening 
depression, this study showed no significant difference between t tests 
comparing Zung scores to Parkinson’s severity. Additionally, there was no 
significant different between SIBS scores and Parkinson’s severity. 
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Using multivariate regression analysis, our model that included age, gender, 
marital status, income, severity of PD, years with PD, and SIBS scores 
accounted for 92% of the variance of depression (R2=0.92). Only gender and 
years with PD were significant variables (p<0.05). 
Discussion 
This pilot study is the first to specifically address the association between 
spirituality and depression in Parkinson’s disease (PD). As prevalent as 
depression is amongst individuals with PD, few studies have specifically 
examined alternatives to pharmacotherapy as treatment for depression in PD. 
As previous studies of spirituality and depression in other populations had 
shown, we expected to see a negative correlation between depression scores 
and SIBS scores (e.g. lower depression scores are associated with high 
spirituality scores). And though we did not find the linear relationship we 
expected, the parabolic model we discovered (p«0.05) poses intriguing 
questions about the interplay between spirituality and depression in PD. It 
appears that the least depressed individuals were either extremely spiritual or 
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not very spiritual at all when compared to the depressed individuals. Why 
might this dichotomy exist? Perhaps those who are very spiritual are “spiritual 
enough” to combat depression effectively, and those not spiritual at ail are 
highly self-reliant and similarly able to fight depression. Does the “half¬ 
heartedness” of those in the middle prevent them from being able to battle 
depression? Perhaps an appropriate analogy would be patients who are given 
a course of antibiotics to treat a particular disease. Cure can be achieved by 
full compliance or even possibly by complete non-compliance, allowing the 
body’s immune system to fend for itself. But partial compliance (Le., taking the 
medicine until you feel better or only when you feel like it) may lead to only a 
partial cure and an illness relapse or development of antibiotic resistance. 
Spirituality may require “full compliance.” 
With the parabolic model being so significant, it is no surprise that we found 
few linear correlations between depression and spirituality. We looked 
specifically at the four domains captured within the SIBS and did find a 
negative linear correlation between the existential/meditative domain and 
depression scores, the implication being that non-depressed individuals (low 
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Zung scores) seemed to utilize existential and meditative methods of 
spirituality. In light of the questions under that domain (“I can find meaning in 
times of hardship”, “My life has a purpose”, questions on the number of times a 
person prayed last week, meditated last week), perhaps those who are able to 
find meaning in their disease and actively pursue spiritual activities such as 
prayer and meditation protect themselves from succumbing to depression. 
Why perceived severity of disease and depression were not correlated 
remains unclear. As mentioned earlier, the mechanism of depression in 
Parkinson’s is poorly understood; perhaps the reason no correlation exists 
between severity and depression is the multifactorial nature of depression in 
PD. We hypothesize that in early Parkinson’s, depression may be mediated 
more by frustration and the initial experience and difficulties of having a 
debilitating movement disorder. In late/severe PD, depression may be driven 
more by neurochemical factors. Hence, individuals with PD may have 
depression over the entire time spectrum they live with the disease; the 
reasons for that depression may change over time, making severity irrelevant. 
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This study revealed much about the use of support groups amongst 
individuals with PD. Most support group attendees were depressed and 
believed that their support group helped them cope with their illness. One 
small study of a Parkinson’s disease support group showed that group 
attendees actively tried to acknowledge and incorporate their illness into their 
everyday life, much more so than non-attendees [36]. Could spirituality be the 
element that enables support group attendees to achieve this? Our study 
showed that using support groups to cope and using spirituality to cope with 
PD were highly correlated, and perhaps it is the support group that gives 
people the structure by which their spirituality can flourish. A German study 
comparing coping strategies between patients with PD, traumatic brain injury, 
stroke, and malignant brain tumors showed that patients with PD tended to 
cope by searching for religious relief or quest for sense more than the other 
groups [37], Armed with this knowledge, healthcare providers for PD patients 
could focus on spirituality as a means of helping them cope with their disease. 
One of the main flaws in this study stem was the small sample size (n=20), 
leaving our data analysis thoroughly underpowered. Based on an alpha of 0.05, 
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a power of 80%, and a standard deviation of 9.7 to detect a 10% difference in 
the Zung Depression Scale, we calculated that 23 patients would need to 
participate. To ensure significance, our goal was to enroll 50 patients. Our 
method of solicitation was the most likely culprit for not reaching our 
recruitment goal. Though over 120 surveys were mailed to over 10 different 
support group leaders, these leaders were sent surveys based on their 
maximum estimate of support group attendance (e.g. if their largest 
attendance was 20, they received 20 surveys). One support group leader sent 
back 5 unused surveys in the mail. A follow-up email and phone call to support 
group leaders verified that group cancellations and other logistical problems 
(bad weather, infrequent meeting times) had delayed the distribution of some 
of the surveys, so we expect to compile and analyze more data over the 
course of the next few weeks. Plans for future mailings to interested support 
group leaders are currently underway. 
Another flaw in our study is the obvious selection bias. Not only were many 
individuals with severe disease unlikely to complete the survey, but also 
almost all of our respondents attended support groups, and though this does 
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not invalidate our results, it certainly prevents us from generalizing our findings 
to the entire Parkinson’s population. The kind of individual who might choose 
to attend a support group may be different from one who does not. A follow-up 
study of non-support group attendees could provide interesting evidence about 
the usefulness of support groups in PD. 
Support groups may provide a comfort zone for individuals with PD, many 
of whom feel stripped by their own bodies of basic human abilities, like that of 
displaying facial emotions. “I feel trapped” is a sentiment shared by many in 
the Parkinson’s community, whose daily battles with their own bodies daily are 
tempered by victories lasting only as long as the last L-dopa dose*. The 
frustration forces many to turn inward; but the war on the exterior eventually 
weeds its way internally, and the fight for the heart, soul, and mind begin. 
When the depression sets in, does it become harder to apologize for wrong 
actions, reexamine one’s spiritual beliefs, or review one’s actions in the 
context of a personal value system? For the Parkinson’s individual at the 
height of depression, the answer may be yes. Spirituality allows the individual 
* From personal anecdotes and interactions with many patients with PD. 
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to rely on a power higher than his/her self and find meaning, a veritable oasis 
in the desert of an incurable disease. 
Does spirituality have a future in the treatment of depression in Parkinson’s 
disease? Pharmacotherapy will continue to be the primary treatment, but we 
hope that healthcare providers will begin to consider a patient’s spirituality as 
part of mental and emotional health assessment. It may prove to be an 
overlooked but important method of addressing the depression that all too 
often accompanies this difficult disease. 
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Appendix: Survey Instruments 
Spirituality and Depression in Parkinson’s Disease Questionnaire 
Please fill out some information about yourself Please do not include your name, as your 
answers are confidential. 
Part I: Basic Demographic Information 
Age_ Gender_ Ethnicity_ Marital Status_ # of children_ 
Do you live alone? Yes or No 
If no, how many people live with you?_ Do they help with your daily activities?_ 
If no, does anyone help with your daily activities? Yes or No 
What is your household income (dollars per year, best guess)? 
_less than $20,000 _ $20-40,000 _ $40-60,000 
_$60-80,000 _$80-100,000 _more than $100,000 
Number of Years you have lived with Parkinson’s Disease: 
Please rank the severity of your disease: 1-no symptoms 2-mild 3-moderate 4-severe 
Religious affiliation: 
Do you consider yourself a religious person? Yes or No 
Do you consider yourself a spiritual person? Yes or No 
Does your support group help you cope with your disease? Yes or No 
On a scale of 1-10 (1= not important at all 10=extremely important), how important is your support 
group in coping with your illness?_ 
Do you live with someone who helps you cope with your disease? Yes or No 
On a scale of 1 -10 (1= not important at all 10=extremely important), how important is your spiritual 
life to coping with your illness? _ 
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Part II: Zung Self-Rating Depression Scale 
Please answer the following questions by checking your response. 
Little or 
none of 
the time 
Some of 
the time 
A large 
part of 
the time 
Most of 
the time 
1.1 feel downhearted, blue and sad 
2. Morning is when 1 feel the best 
3. 1 have crying spells or feel like it 
4. 1 have trouble sleeping through the 
night 
5. 1 eat as much as 1 used to 
6.1 enjoy looking at, talking to, and 
being with attractive women/men 
7. i notice that 1 am losing weight 
8. 1 have trouble with constipation 
9. My heart beats faster than usual 
10. 1 get tired for no reason 
11. My mind is as clear as it used to be 
12. I find it easy to do the things 1 used 
to do 
13. 1 am restless and can’t keep still 
14. 1 feel hopeful about the future 
15. 1 am more irritable than usual 
. . 1 
. 
16. 1 find it easy to make decisions 
17. 1 feel that 1 am useful and needed 
18. My life is pretty full 
19. 1 feel that others would be better off 
if 1 were dead 
20.1 still enjoy the things that 1 used to 
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Part III: Spirituality Involvement and Beliefs Scale 
Please answer the following questions by checking your response. 
Strongly 
Agree 
Agree Neutral Disagree Strongly 
Disagree 
1. In the future, science will be able to explain 
everything. 
0 0 0 0 0 
2.1 can find meaning in times of hardship. 0 0 0 0 0 
3. A person can be fulfilled without pursuing an active 
spiritual life. 
0 0 0 0 0 
4.1 am thankful for all that has happened to me. 0 0 0 0 0 
5. Spiritual activities have not helped me become closer 
to other people. 
0 0 0 0 0 
6. Some experiences can be understood only through 
one’s spiritual beliefs. 
0 0 0 0 0 
7. A spiritual force influences the events in my life. 0 0 0 0 0 
8. My life has purpose. 0 0 0 0 0 
9. Prayers do not really change what happens. 0 0 0 0 0 
10. Participating in spiritual activities helps me forgive 
other people. 
0 0 0 0 0 
11. My spiritual beliefs continue to evolve. 0 0 0 0 0 
12.1 believe there is a power greater than myself. 0 0 0 0 0 
13.1 probably will not reexamine my spiritual beliefs. 0 0 0 0 0 
14. My spiritual life fulfills me in ways that material 
possessions do not. 
0 0 0 0 0 
15. Spiritual activities have not helped me develop my 
identity. 
0 0 0 0 0 
16. Meditation does not help me feel more in touch 
with my inner spirit. 
0 0 0 0 0 
17.1 have a personal relationship with a power greater 
than myself. 
0 0 0 0 0 
18.1 have felt pressured to accept spiritual beliefs that 
I do not agree with. 
0 0 0 0 0 
19. Spiritual activities help me draw closer to a power 
greater than myself. 
0 0 0 0 0 
20. When 1 wrong someone, I make an effort to 
apologize. 
0 0 0 0 0 
21. When I am ashamed of something I have done, I 
tell someone about it. 
0 0 0 0 0 
22.1 solve my problems without using spiritual 
0 0 0 0 
1 
0 
resources. 
23.1 examine my actions to see if they reflect my 
values. 
0 0 0 0 0 
24. During the LAST WEEK, I prayed.... >10 
times 
7-9 
times 
4-6 times 1-3 times zero 
times 
25. During the LAST WEEK, I meditated.... >10 
times 
7-9 
times 
4-6 times 1-3 times zero 
times 
26. During the LAST MONTH, I participated in 
spiritual activities with at least one other person.... 
>15 
times 
11-15 6- 10 1-5 
zero 
times 
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